1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Ontario >
  6. Headlands Research Acquires Toronto Memory Program

M&A Deal Summary

Headlands Research Acquires Toronto Memory Program

On July 7, 2020, Headlands Research acquired leisure company Toronto Memory Program

Acquisition Highlights
  • This is Headlands Research’s 1st transaction in the Leisure sector.
  • This is Headlands Research’s 1st transaction in Canada.
  • This is Headlands Research’s 1st transaction in Ontario.

M&A Deal Summary
Date 2020-07-07
Target Toronto Memory Program
Sector Leisure
Buyer(s) Headlands Research
Deal Type Add-on Acquisition

Target

Toronto Memory Program

Toronto, Ontario, Canada
Founded in 1996 by Drs. Sharon and Ian Cohen, Toronto Memory Program is a community-based clinical trial facility specializing in interventional trials for Alzheimer’s disease and related disorders. The research facility adjoins the largest memory clinic for the diagnosis and clinical care of Alzheimer’s disease and dementia in Canada. Toronto Memory Program has completed over 150 CNS trials since its inception, bringing important Alzheimer’s disease trial opportunities to patients within Canada. In the past year, Dr. Sharon Cohen has been featured on multiple Sponsor panels to announce important drug development milestones, and her work with Alzheimer’s disease has been highlighted in The New York Times.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Headlands Research

Lake Worth, Florida, United States
Category Company
Founded 2018
Sector Life Science
DESCRIPTION

Headlands Research is a multinational integrated clinical trial site organization with a mission to improve lives by advancing innovative medical therapies. Headlands Research was formed in 2018 and is based in Lake Worth, Florida.

DEAL STATS #
Overall 2 of 9
Sector: Leisure M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 9
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-07 JEM Research Institute

Lake Worth, Florida, United States

Founded in 2007 and located in Lake Worth, Florida, JEM Research Institute is a leading CNS research center. The JEM Research Institute physicians have conducted over 200 clinical trials, with a primary focus in CNS. JEM’s 9,500 square foot dedicated research facility boasts over 10 exam rooms, an administrative office suite, and a large patient infusion suite that can accommodate physicians, subjects, and monitors with maximum efficiency and safety. Its founders, Drs. Mark Goldstein and James Goldenberg, the latter of whom is on the Board of Directors of the American Academy of Neurology, are neurologists and highly-regarded key opinion leaders in the neurology field.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-13 Summit Research Network

Portland, Oregon, United States

Summit Research Network provides medical treatment by conducting high-quality scientific research and patient care. Summit Research Network specializes in the areas of psychiatry, dementia, and other age-related memory conditions such as Alzheimer’s and Lewy Bodies, and operates a specialized Memory Health Center. Summit Research Network was founded in 1976 and is based in Portland, Oregon.

Buy -
Mergr

Solution for

Product

Company

Legal